Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 31, Issue 2, Pages 391-402Publisher
WILEY-BLACKWELL
DOI: 10.1002/jbmr.2704
Keywords
GCN5; MSCS; NF-B; OSTEOGENIC DIFFERENTIATION; OSTEOPOROSIS
Categories
Funding
- National Natural Science Foundation of China [81570953, 81500822]
- Program for New Century Excellent Talents in University from Ministry of Education [NCET-11-0026]
- PKU School of Stomatology for Talented Young Investigators [PKUSS20140109]
- Construction Program for National Key Clinical Specialty from National Health and Family Planning Commission of China
Ask authors/readers for more resources
As the most well-studied histone acetyltransferase (HAT) in yeast and mammals, general control nonderepressible 5 (GCN5) was documented to play essential roles in various developmental processes. However, little is known about its role in osteogenic differentiation of mesenchymal stem cells (MSCs). Here, we detected the critical function of GCN5 in osteogenic commitment of MSCs. In this role, the HAT activity of GCN5 was not required. Mechanistically, GCN5 repressed nuclear factor kappa B (NF-B)-dependent transcription and inhibited the NF-B signaling pathway. The impaired osteogenic differentiation by GCN5 knockdown was blocked by inhibition of NF-B. Most importantly, the expression of GCN5 was decreased significantly in the bone tissue sections of ovariectomized mice or aged mice. Collectively, these results may point to the GCN5-NF-B pathway as a novel potential molecular target for stem cell mediated regenerative medicine and the treatment of metabolic bone diseases such as osteoporosis. (c) 2015 American Society for Bone and Mineral Research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available